9 Most Undervalued Healthcare Stocks to Buy Now

Page 3 of 3

6. Bio-Rad Laboratories, Inc. (NYSE:BIO)

PE Ratio: 10.98

Bio-Rad Laboratories, Inc. (NYSE:BIO) is among the most undervalued stocks to invest in.

TheFly reported on April 7 that Citigroup lowered its rating on BIO from Buy to Neutral and reduced its price target from $375 to $300. The revision reflected concerns that the company’s process chromatography segment is unlikely to regain strong growth or margin expansion, despite being a key driver of performance. The outlook was also weighed down by continued uncertainty in Bio-Rad’s diagnostics operations in China, adding further pressure to near-term expectations for the business.

More recently, on April 14, Bio-Rad Laboratories, Inc. (NYSE:BIO) expanded its portfolio of recombinant monoclonal anti-idiotypic antibodies by introducing multiple new highly specific antibody products targeting a range of biotherapeutic drugs, including treatments such as Evenity, Crysvita, Taltz, Empliciti, Sarclisa, Beyfortus, and Imjudo, along with a newly developed antibody for Trulicity.

The company also introduced its first antibody set designed to detect Fc region YTE mutations, supporting more advanced analysis of modified therapeutic antibodies. These additions are intended to improve the accuracy of pharmacokinetic and anti-drug antibody testing used in drug development and monitoring. The new offerings broaden BIO’s capabilities in supporting biologic and biosimilar research with more precise and adaptable bioanalytical tools.

Bio-Rad Laboratories, Inc. (NYSE:BIO) is a global life science company founded in 1952 and based in California. It develops and supplies tools, instruments, and diagnostics for molecular biology, protein research, and clinical laboratory testing.

While we acknowledge the risk and potential of BIO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than BIO and that has 10,000% upside potential, check out our report about this cheapest AI stock.

Click to continue reading and see the 5 Most Undervalued Healthcare Stocks to Buy Now

Disclosure: None. Follow Insider Monkey on Google News.

Page 3 of 3